Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children’s Oncology Group study

Autor: Wistinghausen, Birte, Toner, Keri, Barkauskas, Donald A., Jerkins, Lauren P, Kinoshita, Hannah, Chansky, Pamela, Pezzella, Gloria, Saguilig, Lauren, Hayashi, Robert J., Abhyankar, Harshal, Scull, Brooks, Karri, Vivekanudeep, Tanna, Jay, Hanley, Patrick, Hermiston, Michelle L., Allen, Carl E., Bollard, Catherine M.
Zdroj: In Blood Advances 12 March 2024 8(5):1116-1127
Databáze: ScienceDirect